skip to content

Cambridge Academy of Therapeutic Sciences

 

Developing a Successful Biopharmaceutical Pricing & Market Access Strategy

This course will provide academic researchers working in drug discovery and development with a deep understanding of biopharmaceutical pricing and market access, while outlining the key early considerations which need to be made to allow the right treatment to get to the right patient, at the right time and at the right price. Understanding how basic and early translational research outcomes can impact industry go / no-go and commercial strategy decisions will allow a more holistic view of the challenges and potentials in the development of novel biopharmaceuticals.

Join us for a 7 week virtual course to develop the knowledge and skills required to deliver a successful Life Science commercial strategy and become an industry leader.

7 Virtual Sessions, Once Weekly, 29 April – 17 June 2022; Virtual course, 1pm – 3.30pm Fridays UK time (BST)

 

Registration: Please register for the course here

For full details on the course and speakers, please click here

 

Course Overview

This executive education programme is a collaboration between the Cambridge Academy of Therapeutic Sciences (CATS) and Windrose Consulting Group; experts in value and commercialisation strategies for the Life Sciences industry.

The course is a blend of lectures, case studies and practical exercises. We believe in an interactive approach, encouraging group discussion and exploring real-world situations. The aim is not just to provide the theory, but help you understand how to apply it within your role or future career.  

 

What Will You Learn?   

You will gain an in-depth understanding of how to achieve commercialisation excellence:

Develop and implement a successful Pricing & Market Access strategy

Understand how to pre-empt and address commercialisation challenges

Effectively communicate the value of a drug

Create strategies to adapt to a rapidly changing Life Science landscape

The theory and application of commercialisation strategy; with real life case studies, course work & feedback

 

Who Should Attend?

This course is aimed at present and future Life Science leaders.

Typical participants are:

Those interested in learning about or a career in the Life Sciences industry

Experienced professionals who wish to gain a strong understanding of commercialisation strategy

Those who are entering or transitioning into the commercial side of Life Sciences

Pricing & market access professionals seeking career advancement

 

Course Content

Module 1 - Pricing & Market Access (P&MA) Fundamentals: Friday 29th April 2022 13:00 - 15:30 BST

  • Special guest – Professor Christopher Lowe of Cambridge Academy of Therapeutic Sciences (CATS)  will present his thoughts on “Post-pandemic transformation of the pharmaceutical industry”

An introductory overview of the role of P&MA and value-based pricing, which forms the foundation of any successful commercial strategy.

  • Introduction to Pricing & Market Access

  • P&MA Fundamentals: an introduction to an analytical framework

  • P&MA Fundamentals: positioning


Module 2 - Measuring value through health economics: Friday 6th May 2022 13:00 - 15:30 BST

Quantifying value through health economics and planning for successful health-technology appraisals

  • Introduction to health economics

  • Group Exercise: Health Economics


Module 3 - Stakeholders & Market Systems: Friday 13th May 2022 13:00 - 15:30 BST

Understanding how stakeholders assess value and the decision making process for pricing and access.

  • Integrated stakeholder decision analysis

  • Payer systems & market archetypes


Module 4 - Optimising the P&MA Strategy Part I: Friday 20th May 2022 13:00 - 15:30 BST

Balancing the multitude of practical considerations when developing a P&MA strategy.

  • Research & analysis techniques used by pricing professionals

  • Group exercise: willingness-to-pay (market level)

  • Price policies & optimising “gross-to-net”


Module 5 - Optimising the P&MA Strategy Part II: Friday 27th May 2022 13:00 - 15:30 BST

Balancing the multitude of practical considerations when developing a P&MA strategy

  • Selecting & designing managed entry agreements

  • Global strategy optimisation

  • Optimising pricing strategy across indications


Module 6 - Stakeholder Engagement: Friday 10th June 2022 13:00 - 15:30 BST

Engaging with stakeholders to ensure clear value comprehension to drive successful strategy implementation

  • Group exercise: Managed Entry Agreement selection process

  • Market Shaping

  • Crafting the “Value Story”


Module 7 - Payer Engagement and P&MA Planning: Friday 17th June 2022 13:00 - 15:30 BST

Tools and techniques for negotiation and implementing P&MA strategy throughout the lifecycle

  • Negotiation Strategy

  • P&MA activities throughout the lifecycle

  • Closing Q&A session

 

Course Costs

Professional:

  • Full course £2,500

 

Academics and Students:

  • Full course £1,800

 

What this includes?

This includes course materials (digital copies) and tuition. 

Group discounts may be available on request.

 

Registration: Please register for the course here

 

For more information, please contact:

Georgina Powell, Senior Analyst, Windrose Consulting Group (georgina.powell@windrosecg.com)

Jenny Versnel PhD, Cambridge Academy of Therapeutic Sciences (CATS) (jenny.versnel@admin.cam.ac.uk)